Position in LH
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$405,720
+$3,638 QoQ
Shares Held
1,449
-3.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#626
of 1,040 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $9,148,639 across 10 Diagnostics & Research names. LH ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,787 | $2,901,370 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
3,416 | $1,798,319 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
1,376 | $1,757,853 | |
| 4 | DGX |
Quest Diagnostics Inc
|
2,542 | $538,776 | |
| 5 | DHR |
Danaher Corp /De/
|
2,590 | $493,343 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
1,449 | $405,720 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
705 | $373,360 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,535 | $336,724 |
All Filings in LH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $405,720 | 1,449 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $402,082 | 1,507 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $219,269 | 874 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $283,615 | 988 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $244,396 | 931 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $203,880 | 876 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||